FIBRONEER™ » Globe Newswire - TCN.VN

Pearson VUE’s 2023 Value of IT Certification Candidate Report highlights the importance of certification for career progression in a post-pandemic era 1-02-2023, 13:05

Meltwater partners with Blackbird.AI to combat narrative attacks created by the spread of misinformation and disinformation 22-07-2024, 19:00

Junshi Biosciences Announces Acceptance of the Supplemental New Drug Application for Toripalimab as Perioperative Treatment for Operable NSCLC Patients 12-04-2023, 10:34

19-05-2025, 23:15

Global phase III trials demonstrate that nerandomilast slowed lung function decline in IPF and PPF, with similar discontinuation rates to placebo

Notified -

Globe Newswire19-05-2025, 23:15

10-02-2025, 20:05

Boehringer’s nerandomilast meets primary endpoint in Phase III study FIBRONEER™-ILD, in progressive pulmonary fibrosis

Notified -

Globe Newswire10-02-2025, 20:05

16-09-2024, 17:05

Boehringer’s nerandomilast meets primary endpoint in pivotal phase-III FIBRONEER™-IPF study

Globe Newswire16-09-2024, 17:05

Liên hệ quảng cáo

Hotline hỗ trợ quảng cáo: 0914.222.131
Email: quangcao@vietsoftgroup.com

Email: info@vietsoftgroup.com

© Copyright 2019 - Trang tin tức chuyên đề giới trẻ TCN News - Toàn bộ bài viết được chi sẻ bởi các thành viên.